15 results
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
of increasing responsibility at Novo Nordisk, most recently serving as Senior Vice President, Hemophilia R&D Portfolio. Dr. Prener previously served … . Dr. Shapiro served as Chief Medical Officer and head of R&D at Intercept Pharmaceuticals, Inc., a biopharmaceutical company, from April 2007 to May
8-K
c3n8w5x2
9 Feb 22
Departure of Directors or Certain Officers
4:30pm
DEF 14A
z3tvq9
14 Apr 21
Definitive proxy
7:00am
10-K
7f94t
29 Mar 21
Annual report
6:03am
8-K
EX-99.1
i823fnc
8 Jan 21
Galecto Appoints Anne Prener to its Board of Directors
8:15am
424B4
pescorgl
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1/A
hj0jwvs
22 Oct 20
IPO registration (amended)
6:13am
S-1
wlw1zi912b2nywb
7 Oct 20
IPO registration
5:01pm
DRS
cxnidhp9o9i043
2 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next